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Summary
Vitamin A (retinol) is a prohormone that exerts its pleiotropic biological effects after conversion
into multiple metabolites. In this report we describe the identification of three endogenous, retinol-
derived effector molecules, 14-hydroxy-retro-retinol (14-HRR), anhydroretinol (AR), and retinoic
acid (RA) and a putative storage form of retinol, retinylesters (RE) in the human promyelocytic
leukemia cell line HL-60. Exogenous application of the retinol metabolites in retinol-depleted
serum-free cultures of HL-60 allowed the identification of unique cellular functions for each
metabolite: 14-HRR is a growth factor for HL-60. AR is a functional antagonist of 14-HRR
with growth-inhibiting activity, and RA is a potent inducer of granulocyte differentiation
accompanied by growth arrest. Finally, intracellular RE serves as storage form allowing continuous
production of 14-HRR when no external retinol is available.
V
itamin A (retinol) was discovered nearly a century ago
on the basis of the severe physiological defects that re-
sult from dietary deprivation. Mild vitamin A deficiency affects
night vision, whereas severe depletion causes progressively
worsening syndromes of keratitis of the skin and the eyes,
loss of reproductive capacity, dysfunction of the immune
system and eventually, death (1). Oversupply of vitamin A
is also deleterious to animals in prenatal life, causing severe
deformations (2). Biochemical studies have uncovered sev-
eral metabolites as the molecular mediators that explain some,
but not all, of the pleiotropic effects of vitamin A and the
symptoms of vitamin A deficiency. Retinaldehyde is the
universal chromophore in vertebrate eyes (3). Two forms of
retinoic acid (RA)t, all-traps-RA and 9-cis- RA, have been
linked to a mechanism ofgene activationtermed ligand-assisted
transcriptional regulation, which these retinoids share with
steroid, thyroid, and other small lipophilic hormones (4-6).
RAs function as ligands for two groups of nuclear RA
receptors, referred to as RAR and RXR receptors (7-9). RA
is involved in the development of the embryo and morpho-
genesis (10), which may account for the severe teratogenic
effects of vitamin A. RA isomers also have proven effective
as drugs in the treatment of certain forms of leukemias and
dermatological disorders (11-13) .
Despite these advances in the understanding of RA action,
I Abbreviations used in this paper. AR, anhydroretinol; BHT, butylated
hydroxytoluene; Fn fetalbovine serum; 14HRR, 14hydroxy-retro-retinol;
ITLB, linoleic acid; NBT, nitrobluetetrazolium; RA, retinoic acid; RE,
retinylester.
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it would be too narrow a view to attribute all effector func-
tions ofvitamin A to RA, since several manifestations ofthe
vitamin A deficiency syndrome, among these the immuno-
deficiency and the loss of spermatogenesis, are not reversed
by repletion with RA (14). Two other vitamin A metabo-
lites, 14-hydroxy-retro-retinol (14-HRR) and anhydroretinol
(AR), have recently been identified as putative effector mole-
cules (15, 16). They are both members of the retroretinoid
family, referring to their specific configuration of doublebonds
which gives these molecules a spatial appearance distinct from
retinol and RA. The function of 14-HRR appears to lie in
the support of proliferation of activated B lymphocytes (17)
and functional activation of thymocytes (18), both activities
which RA cannot mediate. AR exhibits inhibitory proper-
ties on lymphocytes that can be reversed by 14-HRR and
retinol (16). All three retinoids, 14-HRR, AR, and RA, are
found side by side in HL-60 cells, prompting us to study
their unique actions in relationship to growth or differentia-
tion of these cells. Our results underscore the view that at
least two different independent effector pathways are regu-
lated by three metabolites with specific functions that are de-
rived from the common prohormone, retinol.
Materials and Methods
Cells and Culture Conditions.
￿
Cells were grown in RPMI 1640
medium containing 10% FCS (Hyclone Laboratories, Logan, UT),
2 mM glutamine plus penicillin and streptomycin (GIBCO BRL,
Gaithersburg, MD). H1r60cells were obtained from the American
Type Culture Collection (Rockville, MD), and tested for myco-
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December 1993 1995-2005plasma twice a month. The defined serum-free medium consisted
of RPMI 1640 with 0.12% BSA, 5 Wg/ml insulin, and 5 ug/ml
transferrin, 10 -6 M linoleic acid (Sigma Chemical Co., St. Louis,
MO), and 2 MM r,-glutamine. 1,25-dihyroxy-vitamin D3 (gift of
Hoffmann-LaRoche, Inc., Nutley, NJ) was dissolved in ethanol.
Differentiation and Proliferation of Cells.
￿
Nitrobluetetrazolium
(NBT, Sigma Chemical Co.) is a yellow dye that when reduced
by oxygen radicals turns black/blue. For detection of differentia-
tion,HIr60cells were tested for their ability to reduce NBT . During
a 30-min stimulation with 10' M PMA (Sigma Chemical Co.),
cells were provided with NBT, 0.61 mM, and analyzed for dark
staining under the microscope (19). The percentage of differen-
tiated cells was given in relation to the total number of viable trypan
blue negative cells. CD11b and CD14 expression was detected by
staining cells with FITC- and PEG-conjugated mAbs CD11b and
CD14 (Amac, Inc., Westbrook, ME) according to the manufac-
turer's manual and analysis on a FRCS® (Becton Dickinson & Co.,
Mountain View, CA) . Morphological evaluation was done under
the microscope with Wright-Giemsa-stained cytocentrifuge slides.
Proliferation was assessed by [3H]thymidine uptake. 30,000
cells/well were seeded in 96-well plates (Falcon, Becton Dickinson,
Lincoln Park, NJ) and 0.8 wCi [3H]thymidine (NEN, Du Pont,
Wilmington, DE) were added to a final volume of 200 p.l/well
for the last 4 h before harvest onto glass filters. ['H]thymidine up-
take was determined by liquid scintillation counting. Assays were
done in triplicates. Cell growth curves were obtained by taking
aliquots from cultures in 12-well cell culture cluster dishes (Costar,
Cambridge, MA) and counting in a Neubauer chamber. Cell
numbers were kept between 5 x 105 and 2 x 106 cells/mm3. Via-
bility was assessed by trypan blue exclusion. Assays were done in
duplicates.
Preparation ofRetinoids.
￿
Retinol (Sigma Chemical Co.) was dis-
solved in ethanol. RA (Sigma Chemical Co.) was dissolved in
DMSO (Fisher Scientific, Fairlawn, NJ). The final concentration
of DMSO in the medium was always <0.0001% and had no effect
on differentiation of the cells. The retinoids werepurified by HPLC
before use. Handling of retinoids was under amber light, and storage
under argon in the dark at -70°C. Radioactive retinol and RA
were purchased from NEN and purified by HPLC before use. 14-
HRR was prepared from lipid extracts of HeLa cells incubated over-
night with 10-5 M retinol and purified to homogeneity by a se-
ries ofthree different HPLC reversed phase columns with different
gradients as described (15). AR was synthesized by acid catalyzed
dehydration ofall-trans-retinol (20). Synthetic AR was purified by
HPLC chromatography. To all retinoids in solution 0.1 mM
butylated hydroxytoluene BHT (Sigma Chemical Co.) was added
as well as to control solvents used in cellular assays.
HPLC ofRetinoids.
￿
Lipid extracts were prepared according to
(21) by suspending cells in 8 parts PBS adding 3.2 parts of
butanol/acetonitrile 1:1, vortexing for 60 s, then adding 2.4 parts
of saturated KZHP04 solution, briefly vortexing again, and then
ultracentrifuging at 14,000 rpm for 4 min. Two partswere removed
from the supernatant and injected in the HPLC (M6000 solvent
deliverypump, photodiode arraydetector; Waters Associates, Mil-
ford, MA) for UV detection or measurement of eluting radioac-
tivity with an on-line scintillation counter (Radiomatic, Tampa,
FL). The gradients went from water, 20 mM Tris buffer, pH 7.4,
or 20 mM glycine buffer, pH 4.5, to methanol to chloroform for
preparative and analytical columns, and from water to acetronitrile
for the semipreparative column in various time frames. The flow
rates were 1.0 ml/min for the analytical C18 (4.6 x 250 mm in-
ternal diameter),4 ml/min for the semipreparative C18 (10 x 250
mm internal diameter), and 8ml/min for the preparative C18 (22
1996
x 250 mm internal diameter) reversed phase columns (Vydac; Sepa-
rations Group, Hesperia, CA). Fractions ofHPLC eluates were col-
lected into polypropylene tubes (Falcon, Becton Dickinson) con-
taining the adequate amount of BHT under protectionfrom light.
Results
HL-60 Leukemia Cells Are Dependent on Vitamin A (Retinol)
for Growth under Serumfree Conditions. A variety of cell lines
including human EBV-transformed B cell lines are depen-
dent on retinol for growth (17). Retinoic acid is not able
to replace the need for retinol (22). To test whether this was
also the case with the human leukemia cell line HL-60, these
cells were cultured under serum-free conditions in medium
containing BSA, transferrin, insulin, and linoleic acid (ITLB).
Proliferation of cells was determined by counting cells in a
Neubauer chamber while assessing viability by trypan blue
exclusion. Cells freshly seeded in ITLB continued to grow
exponentially regardless of the amount of retinol added to
the cultures, for about 1 wk. Thereafter, however, we noted
a marked difference in cultures with or without retinol.
Proliferation of cultures with a retinol concentration of
<10 - e M, when given every 3 d, ceased around day 7 after
transfer to ITLB. By day 9 or 10, viable cellswere no longer
detectable (Fig. 1 a, Fig. 2 a) . In contrast, cells of cultures
with a higher retinol concentration continued to thrive. If
cells of retinol-depleted cultures were replenished with the
vitamin on day 6 the cells resumed growth in a dose-dependent
fashion (Fig. 1 b). The dose optimum for growth was at
10-7 M if fed every 3 d (Fig. 1 a) and 10- e M if fed every
day (Fig. 2 A) . Doses exceeding this concentration did not
stimulate further proliferation. On the contrary, in the range
of 1 to 5 x 10 -6 M, which is optimal for growth in other
cell lines, proliferation was significantly slower than in cul-
tures containing 10 -7 M retinol (17, 18). This was not due
to overt toxicity, because the cells remained intact and via-
bility was consistently >95% by trypan blue exclusion. These
findings demonstrate that retinol is an important cofactor
for both sustenance and control of proliferation of serum-
deprived HL-60 cells.
High Doses ofRetinol Can Induce Granulocytic Differentiation
of HL-60 Cells. A possible explanation for the induction
of growth arrest by high dose retinol was the generation of
a nondividing progeny of differentiated cells. We therefore
tested whether retinol itselfcan induce differentiation in HL-60
cells, as has been suggested previously (23). HL-60 are promy-
elocytic cells that preserve the potential to differentiate to-
wards a variety of cell types including granulocytes, mono-
cytes, and osteoclasts (24, 25). After differentiation in the
granulocytic pathway, they express the ability to reduce the
yellow dye NBT upon stimulation with phorbol esters and
also express lineage-specific antigens such as CR3b (CD11b) .
By contrast, the CD14 antigen is expressed when cells are
driven towards a monocyte-like phenotype (26). To study the
effects ofretinol, HL-60 cells were seeded in serum-free ITLB
medium with different amounts of HPLC-purified retinol.
Cell number and viability were determinedby counting and
trypan blue exclusion. Differentiation was followed by NBT
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Growth of HIr60 under serum-free conditions with ex-
ogenously provided retinoids. HIT60 cells from stock cultures in 10% FBS
were reseeded in serum-free ITLB medium and retinol (A), and 14-HRR
(B) were added daily to the final concentrations shown in legend. Cell
numbers and viability were determined by trypan blue exclusion and mi-
croscopic counting in cultures with different retinoid concentrations. The
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Figure 1 . Growth and differentiation of HL60
promyelocytic leukemia cells under serum-free condi-
tions dependent on the concentration of vitamin A.
(a) HL 60 cells previously cultured in medium con-
taining 10% FBS were reseeded in defined serum-free
medium (ITLB) at day 0. HPLC-purified all-trans-
retinol was added every 3 d to the cultures to yield
final concentrations from 10-6 to 10-9 M in 10-fold
dilution steps and solvent only was added to control
cultures. Cell numbers and viability were determined
each day by microscopic counting. Cell densities were
kept between 5 x 105/ml and 2 x 106/ml by addi-
tion of medium accordingly. The total cell number
ofcultures is plotted over time in different retinol con-
centrations present. (b) Cells cultured in serum-free
medium without retinol until day 6 were then
replenished with the vitamin. Cell numbers were de-
terminedfor thefollowing 3 d in different retinol con-
centration provided to cultures. (c) The percentages
ofNBT positive, differentiated H1T60 cells in the cul-
tures shown in a dependent on the retinol concentra-
tion provided in the medium and for comparison of
cells cultured in 10% FBS.
reduction and by analyzing the proportions ofcellsexpressing
differentiation-specific antigens CD11b and CD14 by fluores-
cence flow cytometry. Below 10 -1 M (if given every 3 d)
or 3 x 10 -8 M (if given daily), retinol did not induce more
than background differentiation (i.e., <5% NBT positive
cells, which occur spontaneously in culture with 10% fetal
bovine serum [FBS]) in HL-60 cells. However, concentra-
tions exceeding those optimal for growth induced differenti-
ation. For instance, by day 8, 60% of the cells in 10-6 M
retinol given every 3 d, or 3 x 10 -7 M daily, were NBT
positive (Fig. 1 c, Table 1). Thus the proportions of differen-
tiated and undifferentiated cells on any givenday was depen-
dent on the concentration of retinol present in that culture.
Cells induced to differentiate by high dose retinol were mor-
phologically indistinguishable from those induced by RA,
had acquired the ability to reduce NBT, and expressed CR3b
but not CD14 (Table 1).
Retinol Derivatives Constitutively Produced in HL-60 Cells.
￿
To
determine which metabolites of retinol were responsible for
the cellular phenomena described above, we characterized the
retinol metabolites produced in HL-60 cells. Initially, cells
were trace-labeled with purified [3H]retinol and lipid ex-
tracts from the cells analyzed by reversed phase HPLC for
retinol metabolites. Several radioactive peaks were character-
ized by coelution with known standards on different HPLC
gradients and by theirbehavior underchanged separation con-
ditions, such as neutral or acidic pH of the elution buffer.
Larger numbers of cells were cultured and treated with cold
cell density was kept between 3 x 105 and 2 x 106 cells/ml by providing
additional culture medium accordingly. Shown is the total cell number
from days 4 through 12 ofculturesdependent on the retinoid concentration.retinol underidentical conditions as in the initial trace-labeling
studies. UV-absorption characteristics ofpreviously identified
radioactive peaks were determined by photodiode array de-
tection of HPLC eluates from lipidextracts ofthese cells and
compared to the UV spectra of known standards. Using these
techniques several distinct metabolites were identified: Retinol
is metabolized by HL-60 cells to compounds both more
lipophilic and hydrophilic than retinol itself (Fig. 3 A) . A
large proportionofretinol is converted into apolar substances
that coelute with retinylesters (RE). Another group of me-
tabolites eluting between retinol and RE on a reversed phase
HPLC gradient corresponds to stereoisomers of compound
3 AR (16, 27). One of the more polar peaks was identified
as 14-HRR (15) (Fig. 3, A and C, compound 2). The struc-
tures are given in Fig. 6.
RA as a Candidate MediatorofRetinol-inducedHL-60 Differen-
tiation. To identify metabolites of retinol that mimic its
differentiating effects, we exposed HL-60cells to 6 x 10-6
M retinol for 2 d, a concentration that eventually induces
granulocytic differentiation in the majority ofcells, and chro-
matographed the lipid extract of these cells by HPLC as de-
scribed in Materials and Methods on a preparative reversed
phase Ct8 column with a linear water/methanol/chloroform
gradient. 1-min fractions were collected for further testing.
Dilutions of fractions 5-45 were added to HL-60 cells and
the proportion of differentiated cells determined after 4 d,
according to the criterion of NBT reduction. We found frac-
tions 12-17 and fractions 27-29 to induce differentiation of
HL-60 cells (Fig. 3 B) . The latter fractions corresponded to
authentic all-trans-retinol by retention time and UV absorp-
tion spectrum (data not shown). The second group confer-
ring differentiating activity (fractions 12-17) comprised a
minor peak in the UV absorption trace. To analyze these
fractions in more detail we rechromatographed the pooled
fractions on an analytical Ct8 reversed phase column. In frac-
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HL 60 cells were cultured under serumfree conditions in the presence of different retinoids as described for Fig. 3. The percentages of differentiated
cells on day 8 of the cultures as measured by the NBT assay and the proportion of cells expressing CR3b (CD11b) and CD14 are shown for different
concentrations of retinol, and 14-HRR used.
ND because of low numbers of viable cells in control cultures.
tions collected of this HPLC analysis, all differentiating ac-
tivity was found within a fraction corresponding to a peak
which displayed a UV absorption maximum at 340 rim. iden-
tical to that of RA (inset, Fig. 3, A and C, compound 1).
This peak also coeluted with authentic RA and exhibited
the same characteristic change in retention time as RA, i.e.,
from 16.5 to 14.5 min, when the pH of the elution buffer
was changed from 7.5 to 4.5. In addition, with a gradient
suitable for separation of RA isomers, the majority of bioac-
tive material was identified as all-trans RA. In addition, we
identified 13-cis- and 9-cis-isomers of RA present in lower
concentrations than the all-trans form. Some differentiating
activity was also detected in the fraction corresponding to
the 9-cis-stereoisomer but not in the fraction containing 13-
cis RA (data not shown). Fractions 24 and 25 containing 14-
HRR, and fractions 31-33 containing AR, did not induce
differentiation.
Next we measured the intracellular concentration of RA
in HL-60 cells as a function of the amount of retinol added
to the cultures. RA levels in HL-60 cells grown in medium
with 10% FCS alone, which contains 1-2 x 10-7 M
retinol, were below the level of detection in our assay (<3
x 10 -9 M). Addition of 5 x 10-6 M exogenous retinol to
the medium increased the intracellular level of RA in HL-60
cells to 1.5 x 10 -7 M (Table 2) after 48 h.
14-HRR Mediates the Growthpromoting Activity ofRetinol.
We observed 14-HRR as a constitutively produced metabo-
lite of retinol in HL-60 cells. To examine the effects of this
compound on HL-60 cells, we evaluated the influences on
cell proliferation and differentiation in HL-60 cell cultures.
We compared serum-free cultures exposed to retinol, or 14-
HRR, measuring growth by counting cells, viabilityby trypan
blue exclusion, differentiation by NBT reduction, and ex-
pression of CD11b and CD14 by FACS® analysis. Retinoids
were added daily since the half-life of 14-HRR in HL-60 cul-
Table 1. Phenotype of HL-60
Concentration of
inducer
Cells on Day 8 of Culture
Percent NBT positive Percent CD11 positive Percent CD14 positive
'um
Retinol 0.3 63 86 0.1
0.1 22 51 0.2
0.03 8.4 27 0.3
14-HRR 0.3 10 22 1.1
0.1 9 23 1.0
0.03 5 20 0.8
Control 9.8B
E
c
N
M
U
C
O
d
O
ac
c
2
fract.
15 on
analyt.
column
RA
2 3
\1 I
0 ' -
10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
retention time (min)
10-
01.111111 . . . . .. ..
10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
n co
2ao 280 280 360 320 340 360 380
￿
2ao 280 280 300 320 340 380 380 400
0
a
240 260 280 300 320 340 360 380 400
Wavelength (nm)
Figure 3.
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Retinol metabolism of HL 60 cells. (A) The lipid extract
of 109 Hh60 cells grown for 2 d in medium containing 10% FBS and
5 /AM retinol analyzed by reversed phase HPLC on a Cis preparative
column with a linear gradient from water to methanol to chloroform.
Shownis theUV absorbance at 324nm dependent on theretentiontime.
(C) (Arrows2and3) Time points whereUVspectra ofcompounds2and
3 in 14-HRR and AR respectively, were obtained. (Inset) Reanalysis of
fractions 12-17 (markedby arrow 1 on preparative analysis) on an analyt-
ical C18 column using adifferent gradient by monitoring UV absorbance
at 340nm.Here RA couldbeidentified accordingto retentiontime, shift
underdifferent pH, andUV absorption spectrum. (B) 1-minfractions of
theeluate from the preparative HPLC analysis were collected andadded
in gradeddilutions beginningwith 1:20to H1T60cellsin ITLR Differen-
tiation of cells in response to added fractions was determined by NBT
reduction after 96 h. Shown is the percentage of NBT positive cells at
adilution of 1:100 for each fraction. (C)(2 and3) UV absorption spectra
obtained at time points of the HPLC analysis in Fig. 2 A marked cor-
respondingly. (1)UV absorption at min 26.8 ofthere-analysis of pooled
fractions 12-17on an analytical reversed phaseHPLC-column. (1, 2, and
3) Correspond exactly to thepublished UV-absorption ofRA, 14-HRR,
and AR respectively.
tures was determined by use of radiolabeled [3H]14-HRR
as < 7h. 14-HRR was able to sustain growth ofHL-60cells
under theseconditions with an efficiency equalto or exceeding
that of retinol (Fig. 2). The growth suppression noted with
high (but not toxic) doses of retinol (Fig. 1) was not found
with thetwo polarretinol metabolites. Cell numbersat doses
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Table 2.
￿
All-traps-RA Levels in HL-60 Cells before andafter 24
and 48 h of Incubation in 5,uM All-Traps-Retinol
Intracellular
Treatment
￿
RA concentration
None
24 h
48 h
f/M
<__0.003"
0.09
0.15
HL-60 were cultured in medium containing 10% FBS for 48 h in the
presence of 5 x 10- 6 Mpurified all-traps-retinol. Before incubation and
after 24 and 48 haliquots of cellswere takenfor HPLC analysis of cellu-
lar retinoids. 0.2 ml of cell pellet was extracted for 24 and 48-h values
and 1 ml of cell pellet of untreated control cells. Retinoids were iden-
tified by correspondence of retentiontime with that of standard material
on equilibrated HPLC column andcharacteristic UV absorption spectra
as well as the pH-dependent characteristic shift of the retention time in
the case of RA. The amount of RA present in thecells was determined
by integration of the area of UV absorbance of the correspondingpeak
and multiplication with the known absorption constant. Indicated are
the intracellular RA concentrations before and after 24 and 48 hofincu-
bation in 5 x 10-6 M retinol.
" Limit of detection by method used.
optimal for growth were higher with 14-HRR than with
retinol; thus 14-HRR was superior in its growth-promoting
activities to that of their precursor, retinol. Conversely, with
respect to cell differentiation, 14-HRR had much lower ac-
tivity than retinol. 14-HRR produced the lowest propor-
tion of differentiated cells only slightly above background
as measured by NBT reduction and expression of differenti-
ation-specific antigens, CD11b and CD14 (Table 1). These
findings indicate a functional dichotomy of retinol metabo-
lites, some serving as growth-promoting agents (14-HRR)
and others inducing differentiation and growth arrest (RA)
(see Fig. 6).
AR Is a Growth Inhibitor of HL-60.
￿
AR is the second
member of the retro-retinoid family found in cells both of
mammal andinsect origin (16, 27). AR is present in HL-60
cells as well (see aboveand Fig. 3).To test the effectsof exog-
enous AR on HL-60 cells, proliferation of cultures exposed
to AR was determined. Thymidine uptake wasmeasured after
20 h of exposure to AR and a pulse of [3H]thymidine for
the last 4 h. Cells freshly transferred to serum-free medium
from a FBS-containing culture before measurement showed
a 50% reduction of thymidine uptake by maximal doses of
AR at 3 x 10-6 M (data not shown). When kept in ITLB
for 3-4 dwithout retinol before exposure to AR, there was
a marked growth suppression whichwasdose dependent and
virtually complete at an AR concentration of 2.5 x 10 -7
M (Fig. 4 A).
AR Inhibits Proliferation ofHL-60withoutInducing Differen-
tiation. Sinceboth AR and RA caused a significant, if not
complete, inhibition of cell growth (Fig. 4 A), it was of in-
terest to ask whether this was due to the same mechanism
andwhetherAR induces HL-60differentiation. AR, retinol,
and RA were added to cultures alone and in combinationa
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Figure 4 .
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Growth suppression ofH1r60byAR andRA and antagonism
ofAR with retinol and 14-HRR . (A) HIT60 were cultured in serum-free
ITLB medium without retinol for 4 d. AR andRA wereadded and prolifer-
ation was measured by [3H]thymidine uptake during the last 4 h of a 24-h
exposure dependent on RA andAR concentrations . (B and C) HIT60cells
were kept in serum-free ITLB without retinol for 4 d . Then they were
reseeded on 96-well plates with 50,000 cells per well. Dilutions of AR
and for eachAR concentration titrations of retinol (B) and 14-HRR (C)
were added . [3H]thymidine uptake was measured during the last 4 h of
the 20-h culture. Shown are cpm of [3H]thymidine uptake at different
retinol and 14-HRR concentrations over the AR concentration .
and differentiation was measured on day 4 dependent on the
concentration of added retinoids . Again, NBT reduction after
stimulation of differentiated cells with PMA as well as ex-
pression ofCR3b (CD11b) were measured. RA led to differen-
tiation of virtually all the cells at doses that caused significant
growth inhibition. AR, in contrast, only led to 20% CD11b
positive (Table 3) and 10% NBT-positive cells (Table 4) at
concentrations that totally abolished growth . CD14, a
monocyte-specific marker, was not found expressed after treat-
ment with AR . Together, these data imply that growth in-
hibition of HL-60 by AR has to take place by means other
than differentiation to granulocytic or monocytic progeny
2000
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cells and is different from the mode by which RA inhibits
growth of these cells.
AR Is a Reversible inhibitor ofRetinol- or 14-HRRpromoted
Growth ofHL-60 cells. We then tested whether AR would
interfere with retinol and its cellular metabolites 14-HRR
with respect to cell growth, thereby inhibiting proliferation
of cells . Cells were kept in ITLB for 3 d and then treated
with various concentrations of AR combined with retinol
or 14-HRR . After 16 h of such exposure, proliferation of
cells again was measured by [3H]thymidine uptake. Retinol,
as well as its metabolite 14-HRR (Fig. 4 B) was able to re-
verse the growth inhibition imposed byAR with similar rel-
ative efficiencies . The reversal was dose dependent and the
ID50 ofAR in this experiment rose from a concentration of
10 -7M in the absence of retinol to 3 x 10-6M in the pres-
ence of 10-7 M retinol . 14-HRR acted similarly. These
findings show that AR acts as a functional antagonist of 14-
HRR and retinol with respect to cell proliferation and that
its growth-suppressing activity is reversible.
AR Does Not Inhibit Differentiation ofHL-60 Cells .
￿
Since
retinol exerts two separate effects on HL-60 cells, growth
and differentiation, and since we found AR to competitively
inhibit retinol-mediated growth, we tested whetherAR would
also interfere with the differentiation-inducing activity ofhigh
dose retinol . Cells were therefore seeded in retinol, AR, or
a combination of the two retinoids . When differentiation was
measured by the ability of the cells to reduce NBT, retinol
showed the expected dose-dependent activity (Table 4) . When
tested in combination, AR did not inhibit retinol-induced
differentiation, unlike the retinol-mediated growth support,
but rather seemed to act in an additive manner. The addition
of 1.25 x 10 -6M AR to 2.5 x 10 -6 M retinol increased
the proportion of NBT-positive cells from 36 to 51% .
To look for effects of AR in combination with other
differentiating agents, HL-60 cells were exposed to it together
with RA or 1,25-dihydroxy-vitamin D3, both known to in-
duce different lineages of differentiation . In terms of induc-
tion of expression of CD11b, the minor activity observed with
AR alone (Table 3) was additive to the activities of 1,25-
dihydroxy-vitamin D3 and RA . A more pronounced effect
ofAR was seen in combination with 1,25-dihydroxy-vitamin
D3 when induction of coexpression of CD14 with CD11b
was measured, which rose from 34% double positive cells
in 1,25-dihydroxy-vitamin D3-treated cultures, to 62% in
cultures which additionally were exposed to 10 -6 M AR .
IntracellularRE Pools Are a Sourcefor Retinoland Its Growth-
promoting Metabolites, 14-HRR . Retinol is esterified efficiently
with a variety of fatty acids to REs by HL-60 (see Fig. 3) .
In animals, REs are the storage form ofretinol and are mainly
found in the liver (14) . To test whether the intracellular RE
pool is used as a retinoid source when exogenous retinol is
absent, we labeled intracellular retinoids by first starving HL-60
cells of retinol for 3 d and then exposing them overnight
to a 5 x 10 -6 M mixture of purified cold and [ 3H]retinol .
After such labeling, 55% of the cell-associated radioactivity
eluted as REs on HPLC, 33% were present as retinol, and
3.5% as 14-HRR, respectively (Table 5) . We followed the
decay of retinol and REs over several days and found thatwithout further exogenous supply, the half-lives were 7.7 h
(retinol) and 48 h (REs) . When external retinol was sup-
plied, the decay was significantly slower (Table 5) . In con-
trast, 14-HRR did not change its intracellular levels (Fig.
5) . We observed in this experiment, that, whereas retinol
and REs progressively disappeared from the cells, 14-HRR
wasmaintained at relatively constant levels throughout aperiod
of 6 d, which exceeded the half-life (< 7 h) by far. The cel-
lular concentrations of 14-HRR only fell when retinol and
REs had been exhausted, which in our experiments always
coincidedwith the loss ofproliferation of cell cultures. Thus,
HL-60 cells were coexposed to known differentiation inducing agents and AR in serum-free ITLB medium for 4 d . Expression of differentiation-
specific antigens CD11bandCD14 was determined by FACS® analysis . Proportions of positive cells within a culture are given for either combinations
of different concentrations ofRA or 2-OH-vitamin D3 with different amounts of AR, cultures treated with AR alone or untreated control cells.
All CD14-expressing cells were coexpressing CD11b .
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Discussion
HL-60 cultures were exposed to retinol, RA or AR . Additionally, a fixed concentration of retinol was combined with graded amounts ofAR and
vice versa . The percent NBT positive cells was determined after 96 h of exposure and is given for the different inducer concentrations of retinol,
AR, and RA alone or the retinol/AR combinations .
tx, toxic inducer concentrations .
as long as retinoland REs are available, and 14-HRR is syn-
thesized in proliferating cells and its cellular concentration
appear to be tightly regulated .
HL-60 cells have become a favored model system for the
study of differentiation owing to the several developmental
options these cells can execute . A variety of inducing agents
can guide the cells selectively to different preordained end-
points. For instance, 1,25-dihydroxy-vitamin D3 causes HL-
Table 3. Influence ofAR
Antigens CD11 b and CD14
on RA or 2-OH Vitamin D3-induced Differentiation Measured by Expression of Differentiation-speck
Percent CD11 positive Percent CD14 positive
AR 1.0 0.1 0.01 0 1 0.1 0.01 0
'um
2-OH-vitamin D3
0.01 99 91 86 83 62 42 38 34
0.001 91 70 66 96 17 13 13 7
RA 0.1 99 97 96 94 1.7 1.1 1 .1 0.9
0.01 87 76 71 71 1.1 0.6 0.7 0.6
Control 23 10 7 7 1.2 0.7 0.8 0.7
Table 4. Differentiation of HL-60 by RA, AR, or Retinol as Measured by NBT
Percent
Reduction Assay
NBT positive
Concentration of
retinoid 5 2.5 1.25 0.6 0.3 0.15 0.08 0
#M
retinol 100 36 22 11 7 7 1 3
AR tx 10 8 2 1 4 2 3
RA 90 55 4
Combinations
retinol + 1 .25 IM AR tx 51 15 10 8 10 8 8
AR + 2.5 P,M retinol tx 54 51 38 38 33 35 36Table 5.
￿
Cellular Retinoid Pools of HL-60 Cells
Intracellular retinoid pool in cells cultured under serum-free conditions with or without vitamin A present in culture medium . HL-60 cells were
grown in defined serum-free medium for 4 d and subsequently exposed to 5 pM cold retinol and additional 10 mCi/ml, 49.3 Ci/mmol retinol over-
night for labeling of intracellular retinoids . Cells were then washed twice in medium alone and reseeded at 5 x 105 cells/ml in ITLB medium
containing either 10 -7 M retinol or no retinol . Lipid extracts of cells were analyzed by reversed phase HPLC on an analytical CIO column and
radioactive peaks identified according to corresponding retention times of known standards in the equilibrated HPLC system as well as codetermina-
tion of the UV absorption spectra . Given are the integrated dpm of corresponding radioactive peaks for 14-HRR, retinol and RE as well as their
proportion in percent total radioactive material recovered from cells of culture aliquots .
Does not add to 100% because of unaccounted metabolites .
60 cells to differentiate to monocyte-like cells, whereas ex-
posure to RA produces cells with a granulocytic phenotype.
We have investigated theHL-60 system with regard to en-
dogenous retinoid production and the effects of these reti-
Figure 5.
￿
Cellular retinoids ofHIMover the course ofculture in serum-
free ITLB. Intracellular retinoids of 141,60 cells were labeled by exposing
cells to a mixture of cold and [3H]retinol overnight . Cells were then
washed and reseeded in ITLB medium . Lipid extracts ofcells ofculture-
aliquots were HPLC analyzed immediately after reseeding and after 2, 4,
6, and 8d ofculture under retinol-free conditions . Shown are the amounts
of labeled retinol derivatives recovered from cells of culture aliquots calcu-
lated from the specific activity ofprecursor [3H]retinol, 14-HRR, retinol,
and RE over time.
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noidswhen applied exogenously. Previous experiments with
retinoids have focused on RA, because of its marked and
specific effect in driving the cells towards granulocyte differen-
tiation . Other investigators have examined the effects ofretinol
and RE and have found both to induce granulocyte differen-
tiation, albeit only when added in high concentrations (20,
28, 29) . By comparison, RA is active at 10-a M, a concen-
tration agreeing with measured binding constants oftheRA
receptors . However, differentiation is not the only aspect of
HL-60 cells governed by retinoids. We describe in this re-
port that HL-60 cells are critically dependent on retinol for
growth under serum-free conditions, a fact not previously
appreciated, and that this effect is mediated by a distinct set
of retinol metabolites.
We identified four retinol metabolites inHL-60 cells, some
of which are well-known and some discovered only very re-
cently : 14-HRR, RA, AR, and a group ofretinyl fatty acid
esters (RE) . Each ofthese has been identified as a metabolite
of retinol on the basis of trace labeling with [3H]precursor
retinol . The molecular identities were defined by (a) posi-
tion in a calibrated HPLC chromatogram and by coelution
with authentic standards ; and (b) by UV spectroscopic mea-
surements, conforming in each case to the published absorp-
tion spectra. In the case ofRA we also used the pH-dependent
shift in retention time as an identifying characteristic. In a
separate report, to be published elsewhere, we show that the
production of all four retinoids depends on intact cells, or
in the case ofAR, can be inhibited by disruption of the elec-
tron transport with sodium azide, ruling out that the simple
Growth Control or Differentiation : Distinct Vitamin A Activities
5 x 106 cells immediately
14-HRR Retinol
dpm
RE Percent total
after labeling 24,700 209,000 397,000
Percent eluate 3.5 33.0 55 .2 91 .7'
5 x 106 cells grown in 10-7 M
retinol for 48 h after
labeling 31,300 147,000 246,000
Percent eluate 5.2 24.6 38 .1 67.9
5 x 10 6 cells grown without
retinol for 48 h after
labeling 34,000 28,000 109,000
Percent eluate 12.8 9.5 39 .0 61 .3dehydration reaction underlying conversion ofretinol toAR
could have occurred spontaneously.
We will now discuss the individual functions of each of
the metabolites and the precursor retinol as well .
The first point is the role of vitamin A itself. This is nor-
mally provided to cultures as a constituent of the serum sup-
plement, and in 10% serum, is present at a concentration
of 1-2 x 10-7M (30) . It has been reported that HL-60 cells
grow in serum-free, i.e., retinol-free, media (31, 19) . Our
findings are in agreement, but only insofar as short-term cul-
tures are concerned. Extended culturing requires in our hands
the addition of retinol in the 10 -7 M range (Fig . 1) . That
HL-60 cells depend after all on an external source of vitamin
A for growthmay have escaped attention previously because
the effects of vitamin A deprivation are not discernible im-
mediately but gradually develop over a prolonged period, i.e.,
in some cases up to 10 d . This is plausibly explained by the
high concentration of endogenous REs (Fig. 3) . We have
monitored these levels over time and find that the RE pool
decays with a half life of48 h under retinol-free culture con-
ditions. Near total depletion of RE coincides with loss of
proliferation and eventual cell death . Whereas the concen-
trations of retinol as well as REs declined rapidly in these
cells, 14-HRR remained at constant steady-state level as long
as the cells were proliferating. In contrast, exogenous 14-HRR
decayed with a half-life of <7 h . Thus, the decline of RE
is associated with continuous production of 14-HRR and
the intracellular concentrations ofwhich is maintained within
close borders . The loss of proliferation is correlated with the
exhaustion of14-HRR, and this is likely to be a direct con-
sequence of depletion ofthe endogenous RE and retinol pools,
from which 14-HRR is synthesized . This leads to our second
point .
The retinol metabolite, 14-HRR is sufficient to sustain
proliferation in retinol-depleted HL-60 cultures. 14-HRR has
not been found to be converted back into retinol (our un-
published results) . 14-HRR can therefore be regarded as the
effector molecule of the growth-promoting retinol activities.
In support of this concept is the continuous proliferation of
HL-60 cells in cultures supplemented with 14-HRR (Fig.
2) and our earlier published findings (18) with lymphocytes,
that 14-HRR is both necessary and sufficient to support cell
proliferation in the absence of exogenous retinol. The en-
dogenous levels of14-HRR are maintained in cells growing
in retinol-free medium as long as the internal RE supply lasts
and proliferation is sustained, as pointed out above.
The third point of discussion concerns the growth-
inhibition mediated by retinol at high concentrations (Figs.
1 and 2) . Confirming earlier reports on this phenomenon
(23) we found that at high concentrations, typically >10 -6
M, retinol induced the differentiation of HL-60 cells, and
this appears to be directly related to the observed decline in
proliferation .The phenotype ofthe differentiated cells identifies
these as granulocytic cells, similar to those arising in response
toRA . Since these cells are terminally differentiated cells with
a limited potential for proliferation the decline of [3H]thymi-
dine incorporation as well as stagnating total cell numbers
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Retinyl esters (RE)
(=Retinol + Fatty Acid Ester)
(STORAGE)
OH
Retinol (Vitamin A)
(PROHORMONE)
Retro-Retinoids
OH
Retinoic Acid (RA)
(DIFFERENTIATION)
14-Hydroxy-Retro-Retinol
￿
Anhydroretinol (AR)
(14-HRR)
(GROWTH SUPPORT)
￿
(GROWTH INHIBITION)
Figure 6 .
￿
Retinoids in H1,60 cells. Intracellular pathways of retinol.
Presented is our current model of cellular retinol metabolism leading to
metabolites with specific activities for either growth support (14-HRR),
negative growth regulation (AR), or differentiation (RA) via indepen-
dent pathways.
in HL-60 cultures exposed to supranormal levels of retinol
is satisfactorily explained by removal of a substantial portion
of cells from the cell cycle .
We propose that the mechanism leading to differentiation
involves the conversion ofretinol to RA . When we assayed
the cellular retinoids of HL-60 cells kept at 5 x 10-6 M
retinol for 48 h for their inherent differentiation-inducing
activities, we found that RA was present at a concentration
of 1.5 x 10 -7M . In standard culture conditions (i.e., 10%
FBS), the cellularRA level was below the limits of detection
in our assay (3 x 10-9 M) .
The molecular basis ofRA action, in contrast to that of
the proliferation-supportive effect of 14-HRR, is better un-
derstood. RA induces differentiation in HL-60 by means of
binding to the nuclear receptor protein RAR-a (32, 33) which
is thought to regulate the transcription ofa set oftarget genes
critical for differentiation (34, 35) . Although our data do not
establish a cause-effect relationship, the amount ofRA gener-
ated intracellularly after exposure to elevated doses of retinol
appears sufficient to saturate the RAR a receptor and ini-
tiate differentiation.
AR, as our fourth point, was described for the first time
as a natural ingredient of fish oils in 1938 (36) . No physio-
logical role has been assigned to this substance. We have found
AR in invertebrate and mammalian cells and tissues (16) . HL-60 cells synthesize AR constitutively, albeit at low concen-
tration (Fig. 3). Although we have not been able to manipu-
late the level of endogenous AR and cannot comment on
its physiological role, we have notedthat exogenous AR exerts
a striking inhibitory effect on the proliferation ofHL-60 cells
(Fig. 4 A). The result of this inhibition is cell death. It is
similar to the antiproliferative effect of AR on lymphocytes
(16). Pharmacologically, AR has all the hallmarks of a re-
versible inhibitor. Both retinol and 14-HRR compete with
AR (Fig. 4, B and C). AR has the same basic retroretinoid
structure as 14-HRR, inviting the speculation that competi-
tion for the same binding protein and displacement ofposi-
tively acting 14-HRR by an inactive analog underlies the ob-
served inhibition.
The effect of AR on the differentiation of HL-60 cells,
and whether or not it may act in an additive manner with
other inducers, is currently unresolved. We have recorded a
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small proportional increaseofdifferentiated cells in AR-treated
cultures, suggesting a weak differentiation-inducing capacity.
However, another explanation may be simply a selective loss
ofthe nondifferentiated HL-60population that may be more
sensitive to the cytostatic or even lethal effects of AR than
the differentiated subpopulation within a culture treated with
AR. The deleterious effectsof AR may differ for cells at dis-
tinct stages of the cell cycle.
In summary, four endogenously produced retinoids ofHL-
60 cells have been linked to distinct physiologic tasks as illus-
trated in Fig. 6 and summarized in Table 5. REs serve as a
storage form of retinol, to be used when external retinol is
scarce. 14-HRR has been implicated in the control ofprolifer-
ation as an essential cofactor, whereas AR appears to func-
tion as a competitive inhibitor of 14-HRR. The function
of RA is control of differentiation towards granulocytes and
this effect is largely independent of 14-HRR and AR.
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